menu
    • menu

    Company profile for Genome & Company

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Genome & Company which is researching and developing dietary supplements, cosmeceuticals, and new drugs utilizing microbiome, pursues people’s happy life. We have been studying microbes and probiotics which can be applied to obesity, diabetes, acne, atopic dermatitis, and cancer complementary therapies with the vision of becoming the Asian Flagship Company of the Human Microbiome Industry and the objective of market drive...
    Genome & Company which is researching and developing dietary supplements, cosmeceuticals, and new drugs utilizing microbiome, pursues people’s happy life. We have been studying microbes and probiotics which can be applied to obesity, diabetes, acne, atopic dermatitis, and cancer complementary therapies with the vision of becoming the Asian Flagship Company of the Human Microbiome Industry and the objective of market driven product development by 2018. We seek to identify what causes diseases, integrating the functional mechanism using a simulator of the human colon microbial ecosystem and multi-omics profiling.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Genome & Companykorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    Silicon Park B-8F 35, Pangyo-ro 255beon-gil, Bundang-gu, Seongnam-si, Gyeonggi...
    Telephone
    Telephone
    +82-31-628-0150
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://genomecom.co.kr/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Debiopharm, Genome Agree On First-In-Class Oncology ADC Family
    Debiopharm, Genome Agree On First-In-Class Oncology ADC Family

    03 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240603093689/en

    BUSINESSWIRE
    03 Jun 2024
    Share Share
    Genome & Co. posts data from phase 2 microbiome cancer trial
    Genome & Co. posts data from phase 2 microbiome cancer trial

    24 Jan 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/genome-company-posts-data-phase-2-microbiome-cancer-trial-plans-more-studies

    FIERCE BIOTECH
    24 Jan 2024
    Share Share
    Positive Results from Interim Analysis of 'GEN-001' Plus avelumab PII Trial
    Positive Results from Interim Analysis of 'GEN-001' Plus avelumab PII Trial

    19 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/positive-results-from-interim-analysis-of-gen-001-plus-avelumab-bavencio-phase-ii-trial-301829278.html

    PR NEWSWIRE
    19 May 2023
    Share Share
    CDMO List Labs Partners with Genome & Company
    CDMO List Labs Partners with Genome & Company

    23 Sep 2021

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2021-09-23/cdmo-list-labs-partners-with-genome-company/?widget=listSection

    CONTRACTPHARMA
    23 Sep 2021
    Share Share
    Rome bags $77M to strike gold in the backwaters of the genome
    Rome bags $77M to strike gold in the backwaters of the genome

    14 Sep 2021

    // Nick Paul Taylor FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/kapeller-s-rome-bags-77m-to-strike-gold-backwaters-genome

    Nick Paul Taylor FIERCEBIOTECH
    14 Sep 2021
    Share Share
    Genome of South Korea purchases CDMO List Labs for $27M
    Genome of South Korea purchases CDMO List Labs for $27M

    09 Sep 2021

    // Kevin Dunleavy FIERCEPHARMA

    https://www.fiercepharma.com/manufacturing/microbiome-developer-genome-south-korea-acquires-cdmo-capability-27m-purchase-list

    Kevin Dunleavy FIERCEPHARMA
    09 Sep 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search